Q32 Bio reports 36-week data from SIGNAL-AA trial’s Part B in alopecia areata Clinical Trials Arena 11:59 Tue, 14 Jul
Q32 Bio Reports Positive 36-Week signal-AA Results In Alopecia Areata; Stock Up In Pre-market RTT News 12:49 Mon, 13 Jul
Q32 Bio Announces Positive 36-Week Topline Results from Part B of the signal-AA Clinical Trial of Bempikibart in Alopecia Areata PR Newswire (Press Release) 12:07 Mon, 13 Jul
Q32 Bio to Report 36-Week Topline Results from Part B of signal-AA Clinical Trial of Bempikibart in Alopecia Areata on July 13, 2026 PR Newswire (Press Release) 21:08 Fri, 10 Jul
